Year archive

ISLAND PHARMACEUTICALS LIMITED — 2026 filings

All 26 regulatory filings released by ISLAND PHARMACEUTICALS LIMITED (ILA) in 2026, sourced directly from the official regulator.

26 Filings

2026 Period

2026 filings (26)

Filing	Released	Lang
Island Adds Biodefence Leader as Filovirus Risks Escalate 6 pages 221.3KB Board/Management Information	2026-05-20	English
Island Bolsters US Biodefence Readiness Ahead of Trials 4 pages 161.4KB Board/Management Information	2026-05-18	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2026-04-27	English
Cleansing Notice 1 page 159.6KB Share Issue/Capital Change	2026-04-27	English
Quarterly Appendix 4C and Activities Report 11 pages 419.9KB Interim / Quarterly Report Q3 2026	2026-04-26	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2026-03-29	English
Cleansing Notice 1 page 137.1KB Capital/Financing Update	2026-03-29	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2026-03-22	English
Cleansing Notice 1 page 137.6KB Share Issue/Capital Change	2026-03-22	English
Antiviral pipeline expansion through strategic collaboration 3 pages 167.9KB Capital/Financing Update	2026-03-08	English
US Government collaboration for Galidesivir development 3 pages 148.5KB Capital/Financing Update	2026-03-03	English
Trading Halt 2 pages 338.6KB Regulatory Filings	2026-03-01	English
Appendix 4D & Half-Year Financial Statements 21 pages 648.4KB Interim / Quarterly Report	2026-02-24	English
Application for quotation of securities - ILA 6 pages 18.3KB Capital/Financing Update	2026-02-15	English
Cleansing Notice 1 page 137.3KB Capital/Financing Update	2026-02-15	English
Response to ASX Query Letter 8 pages 414.6KB Regulatory Filings	2026-02-09	English
Investor presentation 26 pages 1.7MB Investor Presentation	2026-02-04	English
FDA confirms Galidesivir approval pathway 5 pages 206.1KB Capital/Financing Update	2026-02-03	English
$9m placement to advance US biodefence opportunity 3 pages 150.3KB Capital/Financing Update	2026-02-03	English
Proposed issue of securities - ILA 5 pages 17.9KB Capital/Financing Update	2026-02-03	English
Trading Halt 2 pages 320.0KB Regulatory Filings	2026-02-01	English
Quarterly Appendix 4C and Activities Report 10 pages 373.5KB Interim / Quarterly Report	2026-01-26	English
Investor Presentation 25 pages 2.0MB Investor Presentation	2026-01-26	English
US Patent Granted for Galidesivir in filoviridae viruses 2 pages 143.0KB Regulatory Filings	2026-01-06	English
Notification regarding unquoted securities - ILA 6 pages 18.5KB Share Issue/Capital Change	2026-01-05	English
Ongoing engagement with the US FDA 2 pages 139.6KB Regulatory Filings	2026-01-04	English